Cellvizio® is the real-time in vivo cellular imaging platform that revolutionizes the way physicians diagnose and treat patients.
Boston, MA
Joined March 2011
- Tweets2.2K
- Following1.9K
- Followers1.2K
- Likes910
Cellvizio® by Mauna Kea Technologies retweeted
We are proud to introduce a new approach to diagnosing food intolerance in patients with chronic, unexplained gastrointestinal symptoms.
Using advanced endo-microscopy, physicians can observe cellular reactions in the small intestine in real time after introducing specific food particles, helping identify potential food intolerances and guide more personalized dietary recommendations.
For patients living with persistent bloating, diarrhea, abdominal pain and digestive discomfort, this innovative approach can bring greater clarity and a more targeting path to care.
Cellvizio® by Mauna Kea Technologies retweeted
A closer look at real-time cellular food intolerance testing.
We are proud to introduce a new way to identify potential food intolerances in the MENA region for patients with chronic, unexplained gastrointestinal symptoms.
Using advanced endo-microscopy, physicians can observe how the small intestine reacts to specific food particles in real time, helping identify potential food intolerances and guide more personalized dietary recommendations.
For patients experiencing persistent bloating, diarrhea, abdominal pain and digestive discomfort, this innovative approach can provide greater clarity and support a more targeted path to care.
Cellvizio® by Mauna Kea Technologies retweeted
In GIE’s Articles in Press: "The impact of confocal endomicroscopy combined with standard diagnostics in evaluating large pancreatic cystic lesions: an international interobserver study (with video)" by Fred Karaisz et al. giejournal.org/article/S0016…
#GITwitter
@som_krishna
Cellvizio® by Mauna Kea Technologies retweeted
🎙️ 3 Questions à Sacha Loiseau (Mauna Kea Technologies)
@sachaloiseau, Président Directeur Général de @maunakeatech, revient sur le renouveau de la société, les raisons de l'excellente dynamique commerciale aux U.S. et les bonnes performances de Cell Tolerance.
Cellvizio® by Mauna Kea Technologies retweeted
First @CellTolerance cases at @Clinica_Teknon! Powered by #Cellvizio, #CellTolerance helps clinicians identify food triggers for precise, individualized #IBS care. Thrilled that patients in Spain now have access to this revolutionary test!
#GITwitter #guthealth
Cellvizio® by Mauna Kea Technologies retweeted
#ICYMI: This recent feature highlights how @CellTolerance is giving the #IBS community long-awaited clarity. A huge thank you to co-authors @LindaNguyenMD & @DarylDonatelli for showcasing how this is transforming the patient experience.
hubs.la/Q048t5xT0
#Cellvizio
Cellvizio® by Mauna Kea Technologies retweeted
Our strong Q4 performance is a direct reflection of the trust and collaboration we share with our customers and partners. This milestone isn't just a win for our company, but a testament to the powerful community we’ve built together. $ALMKT @maunakeatech maunakeatech.com/news/mauna-…
Cellvizio® by Mauna Kea Technologies retweeted
Thanks @RKiesslich, @uni_mainz_eng, & team for hosting the @CellTolerance workshop! Live #IBS and #GI cases showed how #Cellvizio assesses intestinal barriers in real time to resolve #foodintolerance symptoms through personalized results.
Join future workshops! #GITwitter
Cellvizio® by Mauna Kea Technologies retweeted
Our Q3 2025 revenue results are out, and I'm proud to share that @maunakeatech has seen strong growth in the U.S. with a 31% increase in sales! This outstanding performance is a testament to the hard work and dedication of our entire team. PR: maunakeatech.com/news/mauna-… $ALMKT
Cellvizio® by Mauna Kea Technologies retweeted
Thank you to all who joined our incredible evening in Berlin! Our exclusive educational dinner on endomicroscopic diagnosis of #foodintolerance with @CellTolerance was a tremendous success, bringing together passionate #gastroenterology professionals during #UEGWeek.
#GITwitter
Cellvizio® by Mauna Kea Technologies retweeted
EUS-Guided Needle-Based Confocal Laser Endomicroscopy is an emerging modality for evaluation of PCLs!
⬆️Higher Sensitivity, Specificity and Accuracy!⬆️
#MedTwitter #GITwitter
Cellvizio® by Mauna Kea Technologies retweeted
🤖 Check out the following research paper ➡️ "Artificial Intelligence Advances Digital Pathomics for Confocal Endomicroscopy Diagnosis of Pancreatic Cysts"
🔗 ow.ly/OT0e50Wplcw
Cellvizio® by Mauna Kea Technologies retweeted
Three publications mark our journey from manually curated endomicroscopy (nCLE) videos ➡️ fully autonomous AI model (nCLE AI) that classifies dysplasia in IPMNs.
💡Our latest study - AI outperforming human experts. Congratulations to the OSU AI team, #CLIMB study collaborators!
Cellvizio® by Mauna Kea Technologies retweeted
@ThosaniMD @jorgemachicado @V_Akshintala @MSawhneyMD @jcloydmd @GIPapachristou @EricaParkMD @JordanBurlen @DarylDonatelli @maunakeatech @TaeWoongUSA @Ahmed1Abdelbaki @LattaAlec @Medtronic @FujifilmUS @NanOlogyLLC @OSUWexMed @ASGEendoscopy @AmerGastroAssn @AmCollegeGastro @nickl36
Cellvizio® by Mauna Kea Technologies retweeted
💡The 3rd Annual Pancreatic Cyst Consortium at #DDW2025?
Watch the 🎥full session recording ⬇️
✅ Diagnosis, risk stratification, management, AI, EUS-guided ablation, coding & billing, & the latest advances in the field. Details: linkedin.com/posts/somasheka… youtu.be/xfWUqwJngVs
Cellvizio® by Mauna Kea Technologies retweeted
3rd Annual Pancreatic Cyst Consortium at #DDW2025!
great turnout, engaging talks, lively discussion! Huge thanks to all our incredible speakers, dedicated attendees, and industry sponsors for making it a success.
Cellvizio® by Mauna Kea Technologies retweeted
@jorgemachicado @jcloydmd @MSawhneyMD @V_Akshintala #Anjuli_Luthra #Tamas_Gonda #Fadi_Hawa @DarylDonatelli @sachaloiseau @nickl36 @LattaAlec @maunakeatech @bostonsci @abbvie @medtronic @Olympus_Corp @amplified @NanOlogyLLC @FujifilmUS
Cellvizio® by Mauna Kea Technologies retweeted
🖼️Poster Presentation: Can EUS-nCLE improve diagnosis of pancreatic cysts beyond standard-of-care (CEA, glucose, cytology): Multiobserver cohort adding EUS-nCLE boosted accuracy from 90% → 96% for mucinous vs non-mucinous and improved detection of each PCL subtype #Fred_Karaisz
Cellvizio® by Mauna Kea Technologies retweeted
Very proud and excited to share eight presentations at @DDWMeeting focused on pancreatic cysts from our superb team at OSU.
🗓️ May 3 – Saturday
🎤 Oral Presentations
Towards Automating Risk Stratification of IPMNs: Introducing nCLE-AI, our improved endomicroscopy AI algorithm
Cellvizio® by Mauna Kea Technologies retweeted
Article in Press: "Interobserver agreement in dysplasia grading of intraductal papillary mucinous neoplasms" by Leupold et al. giejournal.org/article/S0016…
@som_krishna @WeiChenMD_GI @AKE_Path @Ahmed1Abdelbaki @zarineshahMD @EricaParkMD @JordanBurlen @HamzaWShah @GIPapachristou
